Steve Olsen Selected Research

Tyrosine Kinase Inhibitors

4/2022

FGFR Fusions as an Acquired Resistance Mechanism Following Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) and a Suggested Novel Target in Advanced Non-Small Cell Lung Cancer (aNSCLC).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steve Olsen Research Topics

Disease

5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 01/2021
4	Neoplasms (Cancer) 01/2023 - 01/2016
2	Breast Neoplasms (Breast Cancer) 01/2016 - 08/2013
1	Colorectal Neoplasms (Colorectal Cancer) 11/2021
1	Aneuploidy (Aneuploid) 01/2021
1	Mental Disorders (Mental Disorder) 01/2019
1	Thrombocytopenia (Thrombopenia) 01/2015

Drug/Important Bio-Agent (IBA)

3	Circulating Tumor DNAIBA 01/2022 - 01/2021
3	Ado-Trastuzumab EmtansineIBA 01/2016 - 08/2013
2	Cell-Free Nucleic AcidsIBA 01/2023 - 01/2021
2	Trastuzumab (Herceptin)FDA Link 11/2021 - 08/2013
2	human ERBB2 proteinIBA 11/2021 - 08/2013
1	DNA (Deoxyribonucleic Acid)IBA 11/2023
1	Complement System Proteins (Complement)IBA 11/2023
1	ErbB Receptors (EGF Receptor)IBA 04/2022
1	Tyrosine Kinase InhibitorsIBA 04/2022
1	pertuzumabIBA 11/2021
1	Adenosine Monophosphate (AMP)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	SDMIBA 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2016
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2016
1	taxaneIBA 08/2013
1	Immunoconjugates (Immunoconjugate)IBA 08/2013

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2016
1	Drug Therapy (Chemotherapy) 08/2013